Peytavin G - Search Results

1

Severe insomnia related to high concentrations of raltegravir.

Eiden C, Peyriere H, Peytavin G, Reynes J. Eiden C, et al. Among authors: peytavin g. AIDS. 2011 Mar 13;25(5):725-7. doi: 10.1097/QAD.0b013e32834465c8. AIDS. 2011. PMID: 21368594 No abstract available.

2

Benefit of treatment interruption in HIV-infected patients with multiple therapeutic failures: a randomized controlled trial (ANRS 097).

Katlama C, Dominguez S, Gourlain K, Duvivier C, Delaugerre C, Legrand M, Tubiana R, Reynes J, Molina JM, Peytavin G, Calvez V, Costagliola D. Katlama C, et al. Among authors: peytavin g. AIDS. 2004 Jan 23;18(2):217-26. doi: 10.1097/00002030-200401230-00011. AIDS. 2004. PMID: 15075539 Clinical Trial.

3

Intermittent viremia during first-line, protease inhibitors-containing therapy: significance and relationship with drug resistance.

Masquelier B, Pereira E, Peytavin G, Descamps D, Reynes J, Verdon R, Fleury H, Garraffo R, Chêne G, Raffi F, Brun-Vézinet F; APROCO/COPILOTE Study Group. Masquelier B, et al. Among authors: peytavin g. J Clin Virol. 2005 May;33(1):75-8. doi: 10.1016/j.jcv.2004.11.012. J Clin Virol. 2005. PMID: 15797369 Clinical Trial.

4

Mutations associated with failure of raltegravir treatment affect integrase sensitivity to the inhibitor in vitro.

Malet I, Delelis O, Valantin MA, Montes B, Soulie C, Wirden M, Tchertanov L, Peytavin G, Reynes J, Mouscadet JF, Katlama C, Calvez V, Marcelin AG. Malet I, et al. Among authors: peytavin g. Antimicrob Agents Chemother. 2008 Apr;52(4):1351-8. doi: 10.1128/AAC.01228-07. Epub 2008 Jan 28. Antimicrob Agents Chemother. 2008. PMID: 18227187 Free PMC article.

5

HIV-2 integrase gene polymorphism and phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitors raltegravir and elvitegravir in vitro.

Roquebert B, Damond F, Collin G, Matheron S, Peytavin G, Bénard A, Campa P, Chêne G, Brun-Vézinet F, Descamps D; French ANRS HIV-2 Cohort (ANRS CO 05 VIH-2). Roquebert B, et al. Among authors: peytavin g. J Antimicrob Chemother. 2008 Nov;62(5):914-20. doi: 10.1093/jac/dkn335. Epub 2008 Aug 20. J Antimicrob Chemother. 2008. PMID: 18718922

6

Selection of the Q148R integrase inhibitor resistance mutation in a failing raltegravir containing regimen.

Roquebert B, Blum L, Collin G, Damond F, Peytavin G, Leleu J, Matheron S, Chêne G, Brun-Vézinet F, Descamps D; ANRS HIV-2 Co5 Cohort. Roquebert B, et al. Among authors: peytavin g. AIDS. 2008 Oct 1;22(15):2045-6. doi: 10.1097/QAD.0b013e32830f4c7d. AIDS. 2008. PMID: 18784469 No abstract available.

7

Early evolution of plasma soluble TNF-alpha p75 receptor as a marker of progression in treated HIV-infected patients.

Morlat P, Pereira E, Clayette P, Derreudre-Bosquet N, Ecobichon JL, Benveniste O, Saves M, Leport C; ANRS CO8 Aproco-Copilote Study Group. Morlat P, et al. AIDS Res Hum Retroviruses. 2008 Nov;24(11):1383-9. doi: 10.1089/aid.2007.0293. AIDS Res Hum Retroviruses. 2008. PMID: 18928394

8

Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults.

Collin F, Duval X, Le Moing V, Piroth L, Al Kaied F, Massip P, Villes V, Chêne G, Raffi F; ANRS CO8 APROCO-COPILOTE study group. Collin F, et al. AIDS. 2009 May 15;23(8):1021-4. doi: 10.1097/QAD.0b013e3283292195. AIDS. 2009. PMID: 19300202 Free PMC article.

9

Maraviroc intensification of stable antiviral therapy in HIV-1-infected patients with poor immune restoration: MARIMUNO-ANRS 145 study.

Cuzin L, Trabelsi S, Delobel P, Barbuat C, Reynes J, Allavena C, Peytavin G, Ghosn J, Lascoux-Combe C, Psomas C, Corbeau P, Flandre P; ANRS 145 MARIMUNO Study group. Cuzin L, et al. Among authors: peytavin g. J Acquir Immune Defic Syndr. 2012 Dec 15;61(5):557-64. doi: 10.1097/QAI.0b013e318273015f. J Acquir Immune Defic Syndr. 2012. PMID: 22986949 Clinical Trial.

10

Impact of gag genetic determinants on virological outcome to boosted lopinavir-containing regimen in HIV-2-infected patients.

Larrouy L, Vivot A, Charpentier C, Bénard A, Visseaux B, Damond F, Matheron S, Chene G, Brun-Vezinet F, Descamps D; ANRS CO5 HIV-2 Cohort. Larrouy L, et al. AIDS. 2013 Jan 2;27(1):69-80. doi: 10.1097/QAD.0b013e32835a10d8. AIDS. 2013. PMID: 23018441

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

498 results

Search Page

Filters